Evidence map›Paper›PMID 23969025›Full record

ReviewMutation research

ITPA (inosine triphosphate pyrophosphatase): from surveillance of nucleotide pools to human disease and pharmacogenetics.

Peter D Simone, Youri I Pavlov, Gloria E O Borgstahl

Open access · greenAbstract readReview
In one paragraph

Review in Mutation research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Arginine-178 is an essential residue for ITPA function.Archives of biochemistry and biophysics · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Inosine monophosphate and inosine differentially regulate endotoxemia and bacterial sepsis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  19. The Effect ofChildren (Basel, Switzerland) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Peter D SimoneThe Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Youri I PavlovThe Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, USA; Department of Pathology and Microbiology, University of Nebraska Medical Center, USA; Department of Genetics, St-Petersburg University, St-Petersburg, 199034, Russia.
Gloria E O BorgstahlThe Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, USA; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, USA. Electronic address: gborgstahl@unmc.edu.
Nebraska Medical Center · USSt Petersburg University · RUUniversity of Nebraska Medical Center · US

Funding

UNMC Structural Biology CoreP20GM103427 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PAUL L SORGEN · 2012 to 2026
$59.2M
UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Joann B. Sweasy · 1985 to 2026
$55.0M
ZINC FINGER-INSPIRED FLUORESCENT CHEMOSENSORSP20RR016469 · NCRR · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI EUDY, JAMES D · 2001 to 2011
$36.2M
Control of Genome Stability by Replicative DNA PolymerasesR01CA129925 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PAVLOV, YOURI I · 2008 to 2012
$1.2M
NCI NIH HHS CA129925NCI NIH HHS P30 CA036727NCI NIH HHS P30CA036727NCI NIH HHS R01 CA129925NCRR NIH HHS 5P20RR016469NCRR NIH HHS P20 RR016469NIAID NIH HHS P200AO70554NIGMS NIH HHS 8P20GM103427NIGMS NIH HHS P20 GM103427
6 · The paper itself

Abstract

Cellular nucleotide pools are often contaminated by base analog nucleotides which interfere with a plethora of biological reactions, from DNA and RNA synthesis to cellular signaling. An evolutionarily conserved inosine triphosphate pyrophosphatase (ITPA) removes the non-canonical purine (d)NTPs inosine triphosphate and xanthosine triphosphate by hydrolyzing them into their monophosphate form and pyrophosphate. Mutations in the ITPA orthologs in model organisms lead to genetic instability and, in mice, to severe developmental anomalies. In humans there is genetic polymorphism in ITPA. One allele leads to a proline to threonine substitution at amino acid 32 and causes varying degrees of ITPA deficiency in tissues and plays a role in patients' response to drugs. Structural analysis of this mutant protein reveals that the protein is destabilized by the formation of a cavity in its hydrophobic core. The Pro32Thr allele is thought to cause the observed dominant negative effect because the resulting active enzyme monomer targets both homo- and heterodimers to degradation.

Indexed as

AnimalsEscherichia coliHumansInosine TriphosphataseMiceModels, MolecularPharmacogeneticsPolymorphism, GeneticPyrophosphatasesYeastsInosine TriphosphataseITPA protein, humanPyrophosphatasesbase analog 6-hydroxylaminopurineBase analogsDominant negativedouble-strand breakDSBHAM1HAPHGPRThomolog RdgB E. coli ITPA homolog (Rec-dependent growth B)hypoxanthine-guanine phosphoribosyltransferaseinosine triphosphateinosine triphosphate pyrophosphataseITPITPAITPA gene polymorphismMEFMercaptopurinesmouse embryonic fibroblastsNucleotide poolnudix (nucleoside diphosphate linked moiety X)-type motif 16NUDT16PharmacogeneticsProtein stabilitySaccharomyces cerevisiaesingle-strand breakSSBthiopurine S-methyltransferaseTPMTxanthosine triphosphateXTP

Identifiers

PMID23969025
PMCPMC3827912
OpenAlexW2108562530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.